About Dapoxetine Hydrochloride API

CH₃ H₃C-O N
Therapeutic Category Premature Ejaculation
CAS Number 129938-20-1
API Technology Synthesis / Small Molecule
Dose Form Tablets
Synergene's Development Status Available
Available Regulatory Filing ODMF

Mechanism of Action

Dapoxetine Hydrochloride operates through targeted therapeutic pathways for premature ejaculation applications. Detailed pharmacological specifications are available upon technical request.

Indication

Indicated for pharmaceutical therapeutic applications in Premature Ejaculation disorders.